Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Boxer

Showing results (21-30 of 328) with videos related to

Pageof 33
Sort By:
Virology|December 26, 2008
The rinderpest virus non-structural C protein blocks the induction of type 1 interferonEmma L Boxer, Sambit K Nanda, Michael D Baron
Journal of Neurophysiology|December 22, 1999
FGF-2 potentiates Ca(2+)-dependent inactivation of NMDA receptor currents in hippocampal neuronsA L Boxer, H Moreno, B Rudy, et al.
The Journal of Clinical Investigation|June 15, 2023
Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenuesNiyatee Samudra, Courtney Lane-Donovan, Lawren VandeVrede, et al.
The Journal of Surgical Research|September 1, 1979
Immunofluorescent staining for factor VIII-related antigen: a tool for study of healing in vascular prosthesesR Dilley, M Herring, L Boxer, et al.
Journal of Clinical and Experimental Neuropsychology|February 5, 2019
Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological StatusKevin Duff, Dana McDermott, Dan Luong, et al.
Neuropathology and Applied Neurobiology|November 14, 2018
Review: Fluid biomarkers for frontotemporal dementiasH Zetterberg, J C van Swieten, A L Boxer, et al.
Frontiers in Neurology|January 7, 2021
Associations Between Amantadine Usage, Gait, and Cognition in PSP: A <i>post-hoc</i> Analysis of the Davunetide TrialMarian L Dale, Barbara H Brumbach, Adam L Boxer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2016
Minimal clinically important worsening on the progressive supranuclear Palsy Rating ScaleSarah Hewer, Sue Varley, Adam L Boxer, et al.
The Lancet. Neurology|February 19, 2022
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerationsBradley F Boeve, Adam L Boxer, Fiona Kumfor, et al.
Practical Neurology (Fort Washington, Pa.)|April 30, 2021
Digital Cognitive Assessments for Dementia: Digital assessments may enhance the efficiency of evaluations in neurology and other clinicsAdam M Staffaroni, Elena Tsoy, Jack Taylor, et al.
Pageof 33

Showing results (21-30 of 328) with videos related to

Sort By:
Pageof 33
Virology|December 26, 2008
The rinderpest virus non-structural C protein blocks the induction of type 1 interferonEmma L Boxer, Sambit K Nanda, Michael D Baron
Journal of Neurophysiology|December 22, 1999
FGF-2 potentiates Ca(2+)-dependent inactivation of NMDA receptor currents in hippocampal neuronsA L Boxer, H Moreno, B Rudy, et al.
The Journal of Clinical Investigation|June 15, 2023
Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenuesNiyatee Samudra, Courtney Lane-Donovan, Lawren VandeVrede, et al.
The Journal of Surgical Research|September 1, 1979
Immunofluorescent staining for factor VIII-related antigen: a tool for study of healing in vascular prosthesesR Dilley, M Herring, L Boxer, et al.
Journal of Clinical and Experimental Neuropsychology|February 5, 2019
Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological StatusKevin Duff, Dana McDermott, Dan Luong, et al.
Neuropathology and Applied Neurobiology|November 14, 2018
Review: Fluid biomarkers for frontotemporal dementiasH Zetterberg, J C van Swieten, A L Boxer, et al.
Frontiers in Neurology|January 7, 2021
Associations Between Amantadine Usage, Gait, and Cognition in PSP: A <i>post-hoc</i> Analysis of the Davunetide TrialMarian L Dale, Barbara H Brumbach, Adam L Boxer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2016
Minimal clinically important worsening on the progressive supranuclear Palsy Rating ScaleSarah Hewer, Sue Varley, Adam L Boxer, et al.
The Lancet. Neurology|February 19, 2022
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerationsBradley F Boeve, Adam L Boxer, Fiona Kumfor, et al.
Practical Neurology (Fort Washington, Pa.)|April 30, 2021
Digital Cognitive Assessments for Dementia: Digital assessments may enhance the efficiency of evaluations in neurology and other clinicsAdam M Staffaroni, Elena Tsoy, Jack Taylor, et al.
Pageof 33